During the past decade, Instituto de Neurocirugía Dr. Asenjo conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto de Neurocirugía Dr. Asenjo" are "Central Nervous System Diseases" (1 trials), "Diagnostic Self Evaluation" (1 trials), "Intracranial Aneurysm" (1 trials) and "Subarachnoid Hemorrhage" (1 trials). Many other conditions were trialed in "Instituto de Neurocirugía Dr. Asenjo" in a lesser frequency.

Most popular intervention types in "Instituto de Neurocirugía Dr. Asenjo" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dotarem (gadoterate meglumine)" (1 trials), "Magnevist (gadopentetate dimeglumine)" (1 trials) and "endovascular coil embolization" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Neurocirugía Dr. Asenjo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Neurocirugía Dr. Asenjo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instituto de Neurocirugía Dr. Asenjo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Neurocirugía Dr. Asenjo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".